However, Garcia also suggested ambivalence in the data [151], SGLT2 inhibitors appear to exert their desirable effects by rapidly reducing angiogenesis and environmental survivability, blocking glucose reabsorption, and encouraging urine glucose excretion, which depletes energy supplies for cancer cells [20]. Here, SLC5A2 is linked to cancer.